At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, James Larkin, FRCP, PhD, of The Royal Marsden, London, UK, provides an overview of the current unmet needs in the treatment of metastatic kidney cancer.
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now